5 Results for "

P-site

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "P-site" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-135878
CAS No.: 6698-26-6
Purity:  99.86%
Research Areas:  

Metabolic Disease

2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site with an IC50 of 3 µM . 2',5'-Dideoxyadenosine is a nucleoside analog and exerts a potent antiadrenergic action in heart .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N6680
CAS No.: 23152-29-6
Synonyms: Virginiamycin S
Virginiamycin S1 (Virginiamycin S) is a streptogramin class B antibiotic. Virginiamycin S1 binds to the bacterial 50S ribosome, occupies the region near the P-site, induces tRNA misreading/stalling, inhibits peptide chain elongation, and exhibits synergistic activity against Gram-positive bacteria when used in combination with Virginiamycin M1 (HY-N6686). Virginiamycin S1 can be used in the research of Gram-positive bacterial infections .
loading...
    loading...
Cat. No.: HY-135878R
CAS No.: 6698-26-6
Research Areas:  

Metabolic Disease

2',5'-Dideoxyadenosine (Standard) is the analytical standard of 2',5'-Dideoxyadenosine. This product is intended for research and analytical applications. 2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site with an IC50 of 3 µM . 2',5'-Dideoxyadenosine is a nucleoside analog and exerts a potent antiadrenergic action in heart .
loading...
    loading...
Cat. No.: HY-185668
CAS No.: 162554-02-1
Target:  

Adenylate Cyclase

Research Areas:  

Others

2',5'-Dideoxy-3'-ATP is an adenylate cyclase inhibitor. 2',5'-Dideoxy-3'-ATP exerts linear noncompetitive inhibition via binding to the distinct P-site. 2',5'-Dideoxy-3'-ATP binds and stabilizes the dimeric form of Mycobacterium avium adenylyl cyclase Ma1120 to inhibit activity .
loading...
    loading...
Cat. No.: HY-202273
CAS No.: 37280-35-6
Target:  

Bacterial

Research Areas:  

Infection

Capreomycin IA is a bactericidal agent targeting bacterial ribosomes, with activity limited primarily to mycobacteria. Capreomycin IA blocks translocation of peptidyl-transfer RNA from the A to the P site to inhibit protein synthesis. Capreomycin IA exerts activity against Mycobacterium tuberculosis. Capreomycin IA can be used for the research of tuberculosis .
loading...
    loading...